The burgeoning UK scene surrounding mind-altering substances is increasingly nuanced, demanding careful exploration. While scientific inquiry into compounds like psilocybin and copyright continues to progress, and patient opportunity via private clinics is increasing, the legal framework remains unclear. This presents a unique situation for both… Read More